Article
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Diabetologia - 1 Jul 2018
Achenbach Peter, Hawa Mohammed I, Krause Stephanie, Lampasona Vito, Jerram Samuel T, Williams Alistair J K, Bonifacio Ezio, Ziegler Anette G, Leslie R David
Abstract excerpt
AIMS/HYPOTHESIS: Adult-onset type 1 diabetes, in which the 65 kDa isoform of GAD (GAD65) is a major autoantigen, has a broad clinical phenotype encompassing variable need for insulin therapy. This study aimed to evaluate whether autoantibodies against N-terminally truncated GAD65 more closely defined a type 1 diabetes phenotype associated with insulin therapy. METHODS: Of 1114 participants with adult-onset...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
